Salek-Ardakani, 2001 - Google Patents
The Role of Interleukin-10 in the Life Cycle of Epstein-Barr VirusSalek-Ardakani, 2001
- Document ID
- 13054202594467179417
- Author
- Salek-Ardakani S
- Publication year
- Publication venue
- PQDT-Global
External Links
Snippet
Viruses employ many diverse strategies to avoid detection by the host immune system. The product of the BCRF-1 open reading frame of EBV exhibits extensive sequence and functional homology with human interleukin-10 (hIL-10) and this has lead to it being termed …
- 108090000174 Interleukin-10 0 title abstract description 663
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/16011—Herpesviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jenkins et al. | Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection | |
| Beaufils et al. | The (YXXL/I) 2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein‐Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. | |
| Ma et al. | Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules | |
| Salek-Ardakani et al. | Epstein–Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV | |
| Carter et al. | The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity. | |
| Schmid | The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8-T cells and is restricted to the DR region of the MHC complex. | |
| KR102190890B1 (en) | Method for activating T cells to treat cancer | |
| Schreiber et al. | Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor. | |
| US5837293A (en) | Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity | |
| Suttles et al. | T cell rescue of monocytes from apoptosis: role of the CD40-CD40L interaction and requirement for CD40-mediated induction of protein tyrosine kinase activity | |
| Salek-Ardakani et al. | High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin | |
| Ahmad et al. | Binding of the Epstein-Barr virus to human platelets causes the release of transforming growth factor-beta. | |
| AU678137B2 (en) | Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity | |
| Ahmed et al. | Negative co-receptors and ligands | |
| Salek-Ardakani | The Role of Interleukin-10 in the Life Cycle of Epstein-Barr Virus | |
| US6316256B1 (en) | Method for protein transfer | |
| CN112543643A (en) | Methods of using soluble CD24 for treatment of acquired immunodeficiency syndrome (HIV/AIDS) | |
| EP1200594B1 (en) | Protective antigen of epstein barr virus | |
| US6319493B1 (en) | Treatment of neoplastic disease with interleukin-10 | |
| Stuart | Structure-function analysis of the interleukin-10 homologue encoded by Epstein-Barr virus | |
| Reiss et al. | Interferon production by cultured murine splenocytes in response to influenza virus-infected cells | |
| Dadas | Development and activity of a single chain CD70 dimer-of-trimer and its potential as a therapeutic immunostimulatory agent | |
| Papageorgiou | Human Lymphoid Cell Lines: in Vitro Models for Study of the Immune Response | |
| Sun | The Role of Dendritic Cells in Promoting Adaptive Antiviral Immune Responses at the Intestinal Mucosa | |
| Snyder | Human pregnancy-specific glycoproteins function as immunomodulators in vitro by inducing secretion of IL-10 and IL-6 in human monocytes |